Loading asset research
ARS Pharmaceuticals Inc. Common Stock
SPRYNasdaq · USD · StocksQuote as of · Exchange session not verified$4.73
-6.52%
Today
SPRY
Loading 1D prices…
Market cap
$473.4M
Volume
2.6M
52w high
$13.1552w low
$4.73Company profile
ARS Pharmaceuticals Inc. Common Stock
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
San Diego, CA, United States
Employees
195
Fiscal year end
1231
CIK
1671858
Session & valuation
Open$5.13
Previous close$5.06
Day high$5.19
Day low$4.73
30-day avg. volume1.7M
Outstanding shares99.4M
Diluted EPS-$1.74
Latest annual period
P/E (trailing)-2.72
P/E (forward)-5.31
Price / book37.78
Beta1.00
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PBYIPuma Biotechnology Inc Common Stock | $470.8M | $228.4M | +13.62% | $0.61 | -0.55% | Hold |
| RLMDRelmada Therapeutics Inc. Common Stock | $482.1M | $0.00 | — | -$1.45 | +11.30% | Buy |
| VOGXVogenx Inc Common Stock | $485.9M | $0.00 | — | -$0.2874 | +9.54% | Buy |
| CAPRCapricor Therapeutics Inc. Common Stock | $486.6M | $0.00 | — | -$2.26 | +0.90% | Hold |
| PRTAProthena Corporation plc Ordinary Shares | $458.4M | $9.7M | -2520.57% | -$4.53 | -1.00% | Hold |